During DOCA-salt-induced hypertension, activation of PPAR-α increases renal tubular cytochrome P450 4A (CYP4A) expression, thereby increasing 20-hydroxyeicosatetraenoic acid (20-HETE) production which affects sodium retention and reduces blood pressure. Here, PPARA is linked to hypertensive disorder.